DEXCOM, INC.

DXCM · NASDAQ

Surgical and Medical Instrument Manufacturing · US

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

ESG Overview

Overall: B (Medium)

E: BS: BG: B

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $61.34 +1.79 (+3.01%)

Market Cap$22.56B

P/E Ratio26.97

EPS$—

52W High$89.98

52W Low$54.11

Beta1.39

Data from Finnhub · Updated May 1, 2026